It started with a belief

Octapharma was founded 40 years ago to provide hemophilia patients with a safer, higher-quality factor VIII (FVIII) concentrate.

News & stories

Check out our latest stories

Heroes in the Fight: Octapharma To Be Honored for Myositis Research at TMA Annual Patient Conference

Octapharma's Prothrombin Complex Concentrate, Balfaxar®, Receives FDA Approval For Warfarin Reversal in Urgent Surgery & Invasive Procedures

Journal of Clinical Immunology Publishes Octapharma USA Research on cutaquig® Evaluating PI Treatment Options

Octapharma USA Grant Supports PANS/PANDAS Education Event at NHIA Conference March 27 in Washington, D.C.

Patient engagement

Octapharma takes an active role in our community

We sponsor and support organizations worldwide.

Learn how we engage with patients

Our products

Products

Learn more about our products to treat rare diseases and other coagulopathies and bleeding disorders.